<oembed>
<success>1</success><type>rich</type><version>1.0</version><cache_age type="integer">86400</cache_age><width type="integer">440</width><height type="integer">500</height><provider_name>RiffReporter</provider_name><provider_url>https://www.riffreporter.de</provider_url><safety>nonadult</safety><asset_type>article</asset_type><url>https://www.riffreporter.de/de/wissen/biotechnologie-novavax-nachtfalter-motte</url><category>Wissen</category><author_name>Kathleen Gransalke</author_name><author_url>https://www.riffreporter.de/de/autorinnen-und-autoren/kathleen-gransalke</author_url><title>Impfstoff aus der Mottenfabrik</title><summary>Novavax stellt die Spike-Proteine für seinen COVID-19-Impfstoff in Insektenzellen her. Das Verfahren ist in der Biotechnologie lange etabliert.</summary><publication_date>27.12.2021</publication_date><thumbnail_url>https://riff.media/images/Kohleule-Novavax.jpg?w=440&amp;h=247&amp;fit=crop-57-47&amp;s=042bf6bdf535cda27239ddc44d9c09c3</thumbnail_url><thumbnail_width type="integer">440</thumbnail_width><thumbnail_height type="integer">247</thumbnail_height><thumbnail_credit></thumbnail_credit><thumbnail_credit_url></thumbnail_credit_url><thumbnail_credit_note></thumbnail_credit_note><html>&lt;html lang=&quot;de&quot;&gt;&lt;iframe src=&quot;https://riff.media/oembed?format=html&amp;url=https%3A%2F%2Fwww.riffreporter.de%2Fde%2Fwissen%2Fbiotechnologie-novavax-nachtfalter-motte&quot; width=&quot;440&quot; height=&quot;550&quot; style=&quot;border: 0; width: 440px; height: 550px;&quot; allowtransparency=&quot;true&quot; allowfullscreen&gt;&lt;/iframe&gt;&lt;/html&gt;</html>
</oembed>
